16 January 2023 - Eli Lilly, Novo Nordisk and Sanofi produce over 90% of the global insulin supply.
The state of California in the US is suing the nation’s largest insulin manufacturers and pharmacy benefit managers for allegedly using their market power to overcharge patients for the life saving drug, the state's attorney general Rob Bonta announced.